Dr. Sidbury was a visionary in pediatric dermatology whose dedication to advancing patient care inspired clinicians, ...

AstraZeneca (AZ) has become the latest major drugmaker to announce a significant investment in the US, committing $50bn into ...

Roche’s oral PI3K inhibitor Itovebi (inavolisib) has been approved by the European Commission (EC) as part of a combination ...

The National Institute for Health and Care Excellence (NICE) has recommended ALK’s once-daily immunotherapy tablet to target ...

Tidmarsh has most recently been serving as adjunct professor of paediatrics and neonatology at Stanford University ...

Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost ...